• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Professional Introduction to 6-Bromo-4-methyl-1H-indazole (CAS No. 885520-98-9)

6-Bromo-4-methyl-1H-indazole is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its versatile structural properties and potential biological activities. This compound, identified by the Chemical Abstracts Service Number (CAS No.) 885520-98-9, belongs to the indazole class, which is known for its presence in various bioactive molecules. The structural motif of indazole, characterized by a benzene ring fused to a pyrrole ring, makes it a valuable scaffold for drug discovery and material science applications.

The synthesis and exploration of 6-Bromo-4-methyl-1H-indazole have been extensively studied in recent years, primarily due to its utility as an intermediate in the preparation of more complex pharmacophores. The bromo and methyl substituents on the indazole ring introduce specific electronic and steric properties that can modulate the reactivity and biological activity of the molecule. This has led to its incorporation in various synthetic pathways aimed at developing novel therapeutic agents.

In the realm of medicinal chemistry, 6-Bromo-4-methyl-1H-indazole has been investigated for its potential role in modulating enzyme activity and interacting with biological targets. Recent studies have highlighted its significance in the development of inhibitors for enzymes such as kinases and phosphodiesterases, which are implicated in numerous diseases, including cancer and inflammatory disorders. The bromine atom, in particular, serves as a handle for further functionalization via cross-coupling reactions, allowing chemists to append diverse functional groups and tailor the molecule's properties for specific applications.

The indazole core itself is a well-documented pharmacophore in medicinal chemistry, with several known drugs featuring this structural motif. For instance, derivatives of indazole have been explored for their antimicrobial, antiviral, and anti-inflammatory properties. The introduction of substituents like bromine and methyl groups enhances the molecular diversity of these compounds, enabling the discovery of new bioactive entities with improved pharmacokinetic profiles.

From a synthetic chemistry perspective, 6-Bromo-4-methyl-1H-indazole represents an important building block for constructing more intricate molecular architectures. The presence of both bromine and methyl groups allows for multiple synthetic strategies, including Suzuki-Miyaura cross-coupling reactions, Buchwald-Hartwig amination, and other transition-metal-catalyzed transformations. These reactions are pivotal in constructing carbon-carbon bonds efficiently, which is crucial for generating complex drug-like molecules.

The pharmaceutical industry has shown particular interest in 6-Bromo-4-methyl-1H-indazole due to its potential as a precursor for small-molecule drugs. Researchers have leveraged its structural features to develop compounds with targeted therapeutic effects. For example, modifications at the 6-bromo position can lead to altered binding affinities to biological targets, while variations at the 4-methyl position can influence metabolic stability and bioavailability.

In addition to its pharmaceutical applications, 6-Bromo-4-methyl-1H-indazole has found utility in materials science. The indazole moiety is known to exhibit interesting electronic properties, making it suitable for use in organic semiconductors and light-emitting diodes (OLEDs). The bromine substituent further enhances its compatibility with various synthetic methodologies used in polymer chemistry and material design.

The latest research trends indicate that 6-Bromo-4-methyl-1H-indazole is being increasingly utilized in combination with other heterocyclic compounds to develop hybrid molecules with enhanced biological activity. Such hybridization strategies often lead to compounds with multiple functionalities, which can exhibit synergistic effects when used as therapeutic agents. This approach aligns with the growing trend toward polypharmacology, where single drugs target multiple disease pathways simultaneously.

The development of computational methods for predicting the biological activity of small molecules has also played a crucial role in the study of 6-Bromo-4-methyl-1H-indazole. High-throughput virtual screening (HTVS) combined with machine learning algorithms has enabled researchers to rapidly identify promising candidates from large chemical libraries. This computational screening has accelerated the drug discovery process and has been instrumental in identifying novel derivatives of indazole-based compounds.

In conclusion, 6-Bromo-4-methyl-1H-indazole (CAS No. 885520-98-9) is a multifaceted compound with significant potential in pharmaceuticals and materials science. Its unique structural features make it an invaluable intermediate for synthesizing bioactive molecules and advanced materials. As research continues to evolve, it is likely that new applications and derivatives of this compound will emerge, further solidifying its importance in scientific endeavors.

• 1082041-34-6(5-Bromo-4-methyl-1H-indazole)
• 1000343-69-0(6-Bromo-5-methyl-1H-indazole)
• 898746-96-8(4-Bromo-1H-indazole-6-carbonitrile)
• 885521-94-8(4-Bromo-6-methyl-1H-indazole)
• 1000343-77-0(4-Bromo-6-isopropyl (1H)Indazole)
• 156454-43-2(5-Bromo-7-methyl-1H-indazole)
• 898747-00-7(6-Bromo-1H-indazole-4-carbonitrile)
• 885223-72-3(5-Bromo-6-methyl-1H-indazole)
• 885272-97-9(7-Bromo-5-methyl-1H-indazole)
• 79762-54-2(6-Bromo-1H-indazole)